111.94

0.01% -0.01

Novo Nordisk Adr (NVO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché NVO Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$111.95

Aprire:

$112.88

Volume 24 ore:

4.43M

Relative Volume:

1.06

Capitalizzazione di mercato:

$498.76B

Reddito:

$37.42B

Utile/perdita netta:

$13.05B

Rapporto P/E:

46.49

EPS:

2.4077

Flusso di cassa netto:

$9.51B

1 W Prestazione:

-1.27%

1M Prestazione:

-5.14%

6M Prestazione:

-13.37%

1 anno Prestazione:

+14.60%

Intervallo 1D:

$111.79

$113.02

Intervallo di 1 settimana:

$107.24

$113.76

Portata 52W:

$94.73

$148.15

Novo Nordisk Adr Stock (NVO) Company Profile

Nome

Novo Nordisk Adr

Settore

Healthcare (1179)

Industria

Drug Manufacturers - General (18)

Telefono

Indirizzo

Dipendente

69,260

Cinguettio

@novonordisk

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

NVO's Discussions on Twitter

Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-05-30	Iniziato	Goldman	Buy
2024-04-12	Iniziato	BMO Capital Markets	Outperform
2024-01-23	Iniziato	Morgan Stanley	Overweight
2024-01-16	Ripresa	UBS	Neutral
2023-12-01	Iniziato	Cantor Fitzgerald	Overweight
2023-10-02	Iniziato	Argus	Buy
2023-07-14	Iniziato	HSBC Securities	Buy
2022-07-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2022-06-28	Downgrade	UBS	Neutral → Sell
2022-06-27	Aggiornamento	Exane BNP Paribas	Underperform → Neutral
2022-06-07	Aggiornamento	JP Morgan	Neutral → Overweight
2022-05-31	Aggiornamento	Guggenheim	Neutral → Buy
2022-04-25	Aggiornamento	Cowen	Market Perform → Outperform
2022-04-12	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2022-03-16	Aggiornamento	Deutsche Bank	Hold → Buy
2022-01-25	Downgrade	Liberum	Hold → Sell
2021-12-20	Downgrade	JP Morgan	Overweight → Neutral
2021-12-17	Downgrade	Deutsche Bank	Buy → Hold
2021-01-20	Downgrade	Credit Suisse	Outperform → Neutral
2021-01-15	Iniziato	Deutsche Bank	Buy
2020-09-29	Iniziato	Berenberg	Hold
2020-07-06	Downgrade	BofA Securities	Buy → Neutral
2020-05-11	Downgrade	UBS	Buy → Neutral
2020-05-04	Iniziato	Cowen	Market Perform
2020-03-16	Aggiornamento	BofA/Merrill	Neutral → Buy
2020-01-03	Downgrade	Guggenheim	Buy → Neutral
2019-11-18	Aggiornamento	Barclays	Equal Weight → Overweight
2019-09-17	Aggiornamento	Citigroup	Neutral → Buy
2019-08-30	Downgrade	Jefferies	Hold → Underperform
2019-06-20	Downgrade	Deutsche Bank	Buy → Hold
2019-06-11	Aggiornamento	Barclays	Underweight → Equal Weight
2019-04-29	Aggiornamento	Credit Suisse	Neutral → Outperform
2019-01-29	Iniziato	Exane BNP Paribas	Outperform
2018-12-11	Ripresa	Jefferies	Hold
2018-10-09	Iniziato	Guggenheim	Buy
2017-12-29	Aggiornamento	JP Morgan	Underweight → Neutral
2017-12-06	Aggiornamento	BofA/Merrill	Neutral → Buy
2017-12-01	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2017-09-25	Downgrade	Exane BNP Paribas	Outperform → Neutral
2017-09-06	Aggiornamento	BofA/Merrill	Underperform → Neutral

Mostra tutto

Novo Nordisk Adr Borsa (NVO) Ultime notizie

Oct 31, 2024

Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? - Benzinga

Oct 31, 2024

Oct 23, 2024

Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo Finance

Oct 23, 2024

Oct 21, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 21, 2024

Oct 18, 2024

Why this money manager sees FirstService, Novo Nordisk and Microsoft as good long-term holdings - The Globe and Mail

Oct 18, 2024

Oct 16, 2024

Monitoring Melco Resorts & Entertainment Ltd ADR (MLCO) after recent insider movements - Knox Daily

Oct 09, 2024

Oct 07, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024

Oct 03, 2024

Novo Nordisk Currently Down Six Consecutive Days, on Pace for Longest Losing Streak Since September 2022 — Data Talk - Morningstar

Oct 03, 2024

Oct 02, 2024